Hims Is Reaching 3 Million Member Milestone
Summary
Parkev analyzes Hims & Hers as a company poised to disrupt the healthcare industry, where widespread consumer dissatisfaction creates a massive opening for new market entrants. Parkev highlights the company's impressive scale, noting that revenue has grown from $150 million in 2020 to over $2.6 billion recently, supported by a growing member base of nearly 3 million people. Parkev believes that the industry is ripe for change, unlike the payment processing industry, because healthcare consumers are generally unhappy with current outcomes.
Despite the strong top-line growth, Parkev expresses some concern regarding declining margins and a decrease in the return on invested capital, which fell from a peak of 35% in early 2025 to -8.4%. Parkev notes that while the company is generating a positive operating cash flow of over 10% of revenue, it continues to invest heavily in marketing, production, and international expansion (such as the Eucalyptus acquisition) to capture a larger share of the market. This internal cash generation is seen as a major risk mitigator as it reduces the need for external capital raises.
Regarding valuation and entry points:
Mentioned Stocks
Reasoning: Parkev identifies Hims & Hers as a disruptor in a healthcare industry full of dissatisfied customers, citing a massive jump in revenue from $150 million in 2020 to $2.6 billion today. Parkev notes that the company is now cash-flow positive, which reduces the risk of needing to raise emergency capital. While Parkev calculates a fair value of $26.90 (close to the current price of $27.72) and reaffirms a medium conviction buy rating, Parkev suggests waiting for a volatile dip to gain a larger margin of safety.